Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Other financing activities (2022 - 2024)

Phibro Animal Health (PAHC) has 3 years of Other financing activities data on record, last reported at $10.4 million in Q3 2024.

  • For Q3 2024, Other financing activities changed N/A year-over-year to $10.4 million; the TTM value through Jun 2025 reached $10.4 million, changed N/A, while the annual FY2025 figure was $10.4 million, N/A changed from the prior year.
  • Other financing activities reached $10.4 million in Q3 2024 per PAHC's latest filing, up from $833000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $10.4 million in Q3 2024 and bottomed at $71000.0 in Q3 2022.
  • Average Other financing activities over 3 years is $3.0 million, with a median of $701000.0 recorded in 2022.